Upgrade to SI Premium - Free Trial

Pfizer (PFE) PT Raised to $45 at Goldman Sachs

August 28, 2018 7:48 AM
Goldman Sachs analyst Jami Rubin raised the price target on Pfizer (NYSE: PFE) to $45.00 (from $42.00) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst EPS Change Analyst PT Change

Next Articles